Morning Briefing
Summaries of health policy coverage from major news organizations
Private Insurers Clamp Down On Drug Prices
More health plans are refusing to cover certain brand-name drugs unless drugmakers agree to offer discounts for them, reports The New York Times. Meanwhile, drug companies are trying to change a federal program designed to allow certain hospitals that treat large numbers of the poor to buy drugs more cheaply, but which critics say allows them to use those savings to pad profits.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
